Neurogastroenterol Motil. 2021 Jan;33(1):e13885. doi: 10.1111/nmo.13885. Epub 2020 Jun 22.
PMID:32573076
Aldosterone synthase inhibitor (BI 690517) therapy for people with diabetes and albuminuric chronic kidney disease: A multicentre, randomized, double-blind, placebo-controlled, Phase I trial.
Bornstein SR, de Zeeuw D, Heerspink HJL, Schulze F, Cronin L, Wenz A, Tuttle KR, Hadjadj S, Rossing P.